Skip to Main Content

Paper Details

Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards.
BMC Med
6
2022
Author NameAffiliation
Damian T RiekeComprehensive Cancer Center, Charite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
Damian T RiekeCharite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
Damian T RiekeBerlin Institute of Health (BIH) at Charite - Universitatsmedizin Berlin
Damian T RiekeGerman Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)
Peter HorakGerman Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)
Peter HorakNational Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ)
Benedikt BrorsGerman Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)
Benedikt BrorsGerman Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)
Albrecht StenzingerInstitute of Pathology, University Hospital Heidelberg
Stefan Fr??hlingGerman Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ)
Stefan Fr??hlingNational Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ)
  • 1 - 11

Datasets